Eye Catching Stocks : Celgene Corporation (NASDAQ:CELG), Bankrate, Inc. (NYSE:RATE), China Ming Yang Wind Power Group Limited (NYSE:MY), GILD, AxoGen, Inc. (NASDAQ:AXGN)

On Oct 20, Sequenta, Inc., announced an equity investment by Celgene Corporation (NASDAQ:CELG) and other strategic investors. This financing, in addition to funding secured from several other strategic investors, will support incorporation of the ClonoSIGHT™ minimal residual disease (MRD) test into clinical trials of medicines in development for various hematological malignancies (blood cancers) and development of new clinical diagnostics based on Sequenta’s revolutionary LymphoSIGHT™ platform. … Continue reading Eye Catching Stocks : Celgene Corporation (NASDAQ:CELG), Bankrate, Inc. (NYSE:RATE), China Ming Yang Wind Power Group Limited (NYSE:MY), GILD, AxoGen, Inc. (NASDAQ:AXGN)

Watch List: Digimarc Corporation (NASDAQ:DMRC), Autohome (NYSE:ATHM), Gilead Sciences (NASDAQ:GILD), Comtech Telecommunications Corp. (NASDAQ:CMTL), Heron Therapeutics, Inc. (NASDAQ:HRTX)

Digimarc Corp. (NASDAQ:DMRC) CEO Bruce L. Davis sold 5,000 shares of Digimarc Corp. stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $24.66, for a total transaction of $123,300.00. Following the completion of the sale, the chief executive officer now directly owns 5,000 shares of the company’s stock, valued at approximately $123,300.  Digimarc Corporation (NASDAQ:DMRC) belongs to Technology … Continue reading Watch List: Digimarc Corporation (NASDAQ:DMRC), Autohome (NYSE:ATHM), Gilead Sciences (NASDAQ:GILD), Comtech Telecommunications Corp. (NASDAQ:CMTL), Heron Therapeutics, Inc. (NASDAQ:HRTX)

Stocks to Watch : Gilead Sciences Inc. (NASDAQ:GILD), Sprint (NYSE:S), DWSN, Prana Biotechnology Limited (NASDAQ:PRAN), Lime Energy (NASDAQ:LIME)

Gilead Sciences (NASDAQ:GILD) CFO Robin L. Washington sold 33,556 shares of the stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $95.56, for a total transaction of $3,206,611.36. Following the completion of the sale, the chief financial officer now directly owns 49,832 shares of the company’s stock, valued at approximately $4,761,946. The sale was disclosed in a filing with the … Continue reading Stocks to Watch : Gilead Sciences Inc. (NASDAQ:GILD), Sprint (NYSE:S), DWSN, Prana Biotechnology Limited (NASDAQ:PRAN), Lime Energy (NASDAQ:LIME)

Nasdaq active movers: Facebook Inc (NASDAQ:FB), Sirius XM Holdings (NASDAQ:SIRI), QUALCOMM (NASDAQ:QCOM), Glu Mobile Inc. (NASDAQ:GLUU), Gilead Sciences, Inc. (NASDAQ:GILD)

Facebook Inc said the US Securities and Exchange Commission dropped its probe into the social networking company over events surrounding its controversial initial public offering. Facebook Inc (NASDAQ:FB) stock performance was 0.28% in last session and finished the day at $75.19. Traded volume was 385.00million shares in the last session and the average volume of the stock remained 49.28million shares. Facebook Inc (NASDAQ:FB) insider ownership … Continue reading Nasdaq active movers: Facebook Inc (NASDAQ:FB), Sirius XM Holdings (NASDAQ:SIRI), QUALCOMM (NASDAQ:QCOM), Glu Mobile Inc. (NASDAQ:GLUU), Gilead Sciences, Inc. (NASDAQ:GILD)

Healthcare ACtive Stocks: MannKind (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Bristol-Myers Squibb Co (NYSE:BMY)

MannKind Corporation (NASDAQ: MNKD) is a small company based in Valencia, California, poised to launch its FDA approved drug, Afrezza, as treatment indications for both Type 1 and Type 2 diabetes. Despite near unanimous backing from experts at the Advisory Committee (ADCOM) and the medical community, Mr. Market is still pessimistic on the company.  MannKind Corporation (NASDAQ:MNKD) stock performance was -2.50% in last session and finished the … Continue reading Healthcare ACtive Stocks: MannKind (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Bristol-Myers Squibb Co (NYSE:BMY)

Investors Alert – Gilead Sciences (NASDAQ:GILD) , Galena Biopharma (NASDAQ:GALE) , RPI , UnitedHealth (NYSE:UNH) , China Automotive (NASDAQ:CAAS)

Gilead Sciences’ controversial $1,000-a-day Sovaldi pill is priced in line with previous treatments for Hepatitis C, but the nation’s health-care system likely won’t be able to handle that kind of sticker shock, and competition probably will bring down that price tag in coming months and years. Gilead Sciences, Inc. (NASDAQ:GILD) stock performance was 4.84% in last session and finished the day at $89.19. Traded volume … Continue reading Investors Alert – Gilead Sciences (NASDAQ:GILD) , Galena Biopharma (NASDAQ:GALE) , RPI , UnitedHealth (NYSE:UNH) , China Automotive (NASDAQ:CAAS)